Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age‐related macular degeneration
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Physiologically, the retinal pigment epithelium ( RPE ) expresses immunosuppressive signals such as FAS ligand ( FASL ), which prevents the accumulation of leukocytes in the subretinal space. Age‐related macular degeneration ( AMD ) is associated with a breakdown of the subretinal immunosuppressive environment and chronic accumulation of mononuclear phagocytes ( MP s). We show that subretinal MP s in AMD patients accumulate on the RPE and express high levels of APOE . MP s of Cx3cr1 −/− mice that develop MP accumulation on the RPE , photoreceptor degeneration, and increased choroidal neovascularization similarly express high levels of APOE . ApoE deletion in Cx3cr1 −/− mice prevents pathogenic age‐ and stress‐induced subretinal MP accumulation. We demonstrate that increased APOE levels induce IL ‐6 in MP s via the activation of the TLR 2‐ CD 14‐dependent innate immunity receptor cluster. IL ‐6 in turn represses RPE FasL expression and prolongs subretinal MP survival. This mechanism may account, in part, for the MP accumulation observed in Cx3cr1 −/− mice. Our results underline the inflammatory role of APOE in sterile inflammation in the immunosuppressive subretinal space. They provide rationale for the implication of IL ‐6 in AMD and open avenues toward therapies inhibiting pathogenic chronic inflammation in late AMD .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 1×
“HLA-DR and CD68positive MP dendrites have previously been observed in smaller, dome-shaped drusen (Hageman et al, 2001).”
BackgroundThe epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Ageing and degeneration in the macular region: A clinico-pathological study
Sarks, S. H. (1976) · British Journal of Ophthalmology · doi:10.1136/bjo.60.5.324 · Cited by 891 · cited 1×
“…of supernatant protein from peritoneal M/s also showed increased APOE secretion (Fig 3G) in the Cx3cr1GFP/GFP samples when compared to the soluble Mer receptor tyrosine kinase that is released constitutively from cultured macrophages (Sather et al, 2007) and which served here as a loading control.”
BackgroundWhat is immune privilege (not)?
Galea, I., Bechmann, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.004 · Cited by 768 · cited 1×
“A number of neuron- and glialderived factors (e.g., CX3CL1, CD200L) repress their activation (Galea et al, 2007).”
BackgroundCombadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618 · cited 7×
“Cx3cr1 deficiency in mice leads to a strong increase of subretinal MP accumulation with age, after light challenge or laser injury (Combadiere et al, 2007; Raoul et al, 2008; Ma et al, 2009), in A B C D E F G H Figure 1.”
BackgroundInfluentialSelf-citationPeri, F., & Nüsslein-Volhard, C. (2008) · Cell · doi:10.1016/j.cell.2008.04.037 · Cited by 617
Gupta, N., Brown, K. E., & Milam, A. H. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00332-9 · Cited by 582
Chen, W., Stambolian, D., Edwards, A. O., Branham, K. E., Othman, M., Jakobsdottir, J., Tosakulwong, N., Pericak-Vance, M. A., Campochiaro, P. A., Klein, M. L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912702107 · Cited by 506 · cited 1×
“Furthermore, a polymorphism of the ATP binding cassette transporter 1 (ABCA1, associated with low HDL and therefore possibly impaired RCT) has recently been shown to be protective against advanced AMD (Chen et al, 2010).”
BackgroundGenetic Association of Apolipoprotein E with Age-Related Macular Degeneration
Klaver, C. C. W., Kliffen, M., van Duijn, C. M., Hofman, A., Cruts, M., Grobbee, D. E., van Broeckhoven, C., & de Jong, P. T. V. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301901 · Cited by 498
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
Linton, M. F., Atkinson, J. B., & Fazio, S. (1995) · Science · doi:10.1126/science.7863332 · Cited by 478 · cited 1×
“APOE is expressed in the liver (Linton et al, 1995), is a major component of high-density lipoproteins (HDL) of the blood (Mahley & Rall, 2000), and is the main lipoprotein of the brain and the retina (Mahley & Rall, 2000; Anderson et al, 2001).”
BackgroundSeddon, J. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.6.774 · Cited by 354 · cited 2×
“Recently, it has been shown that increased IL-6 levels are associated with AMD incidence (Klein et al, 2014) and with late AMD (Seddon et al, 2005; Klein et al, 2008).”
BackgroundImpact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 346 · cited 4×
“MPs have been reported to express APOE at high levels (Basu et al, 1982; Rosenfeld et al, 1993; Nakai et al, 1996; Peri & NussleinVolhard, 2008).”
BackgroundResultInfluentialHuman Apolipoprotein E4 Domain Interaction
Dong, L.-M., & Weisgraber, K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19053 · Cited by 318
Tsutsumi, C., Sonoda, K.-H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902436 · Cited by 277 · cited 1×
“It is generally admitted that MPs play an important role in CNV (Sakurai et al, 2003; Tsutsumi et al, 2003).”
BackgroundAnderson, D. H., Ozaki, S., Nealon, M., Neitz, J., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00961-2 · Cited by 255 · cited 5×
“This hypothesis is, however, in contradiction with the APOE accumulation observed in AMD donor eyes (Klaver et al, 1998; Anderson et al, 2001) and the protective effect of the APOE4 allele in AMD (McKay et al, 2011).”
BackgroundResultInfluentialA dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity
Guo, L., LaDu, M. J., & Van Eldik, L. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:205 · Cited by 175
McKay, G. J., Patterson, C. C., Chakravarthy, U., Dasari, S., Klaver, C. C., Vingerling, J. R., Ho, L., de Jong, P. T. V. M., Fletcher, A. E., Young, I. S., et al. (2011) · Human Mutation · doi:10.1002/humu.21577 · Cited by 151 · cited 3×
“Homozygous APOE2-allele carriers are at increased risk for developing late AMD (recently confirmed in 20,000 subjects (McKay et al, 2011)) and are protected against Alzheimer’s disease (AD), while the APOE4 allele protects against AMD and is a risk factor for AD (Mahley & Rall, 2000).”
BackgroundResultImpaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139 · cited 1×
“The structural changes in the APOE4 protein, however, lead to diminished association with HDL (Dong & Weisgraber, 1996) and impaired reverse cholesterol transport (Heeren et al, 2004).”
BackgroundApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
Mooijaart, S. P., Berbée, J. F. P., van Heemst, D., Havekes, L. M., de Craen, A. J. M., Slagboom, P. E., Rensen, P. C. N., & Westendorp, R. G. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030176 · Cited by 129 · cited 2×
“(Mahley & Rall, 2000; Mooijaart et al, 2006; Riddell et al, 2008; Malek et al, 2005).”
BackgroundRegulated expression of apolipoprotein E by human retinal pigment epithelial cells
Ishida, B. Y., Bailey, K. R., Duncan, K. G., Chalkley, R. J., Burlingame, A. L., Kane, J. P., & Schwartz, D. M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300306-jlr200 · Cited by 111 · cited 1×
“In vitro, the RPE has been shown to secrete APOE preferentially to its basal side (Ishida et al, 2004).”
BackgroundInflammation, Complement Factor H, and Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Klein, B. E. K., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.03.021 · Cited by 106 · cited 2×
“Recently, it has been shown that increased IL-6 levels are associated with AMD incidence (Klein et al, 2014) and with late AMD (Seddon et al, 2005; Klein et al, 2008).”
BackgroundSurvey of common eye diseases in laboratory mouse strains.
Chang, B., Hurd, R., Wang, J., & Nishina, P. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12289 · Cited by 97
Crosstalk between reverse cholesterol transport and innate immunity
Azzam, K. M., & Fessler, M. B. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.02.001 · Cited by 96
Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells
Raoul, W., Keller, N., Rodéro, M., Behar-Cohen, F., Sennlaub, F., & Combadière, C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.014 · Cited by 60 · cited 3×
“(Mahley & Rall, 2000; Mooijaart et al, 2006; Riddell et al, 2008; Malek et al, 2005).”
BackgroundSelf-citation
Cited by
Cochain, C., Vafadarnejad, E., Arampatzi, P., Pelisek, J., Winkels, H., Ley, K., Wolf, D., Saliba, A.-E., & Zernecke, A. (2018) · Circulation Research · doi:10.1161/circresaha.117.312509 · Cited by 894
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
Self-citationOn phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
Self-citationComplement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Calippe, B., Augustin, S., Beguier, F., Charles-Messance, H., Poupel, L., Conart, J.-B., Hu, S. J., Lavalette, S., Fauvet, A., Rayes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.006 · Cited by 168
Self-citationMargeta, M. A., Yin, Z., Madore, C., Pitts, K. M., Letcher, S. M., Tang, J., Jiang, S., Gauthier, C. D., Silveira, S. R., Schroeder, C. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.014 · Cited by 130
Metadata
- Authors
- Levy, O., Calippe, B., Lavalette, S., Hu, S. J., Raoul, W., Dominguez, E., Housset, M., Paques, M., Sahel, J., Bemelmans, A., Combadiere, C., Guillonneau, X., & Sennlaub, F.
- Venue
- EMBO Molecular Medicine
- Published
- 2015-01-20
- Volume
- 7
- Issue
- 2
- Pages
- 211-226
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2110234456
- Cited by
- 137
- References
- 24
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.